Home
Conditions
Severe Eosinophilic Asthma

Clinical trial condition

Severe Eosinophilic Asthma

Explore clinical trials studying Severe Eosinophilic Asthma. Study availability and eligibility vary by location and protocol.

14 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Severe Eosinophilic Asthma trial results

Not yet recruiting

Real-World Effectiveness of Depemokimab in Allergic Bronchopulmonary Aspergillosis With Severe Eosinophilic Asthma

NCT07828327

Conditions: ABPA, Allergic Bronchopulmonary Aspergillosis, Aspergillosis, +20 more
Locations: Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, #16766, Jingshi Road, Jinan City, Shandong Province, China Jinan, Shandong, China

View Trial Details

Enrolling by invitation

Fasenra: An Asthma Study

NCT07654842

Conditions: Asthma, Bronchial Diseases, Eosinophilia, +15 more
Locations: Endeavor Health Skokie, Illinois, United States

View Trial Details

Active, not recruiting

Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic Asthma

NCT06069310

Conditions: Chronic Rhinosinusitis With Nasal Polyps, Chronic Rhinosinusitis Without Nasal Polyps, Eosinophilia, +14 more
Locations: Pulmonary Dept First ICU, Evagelismos Hospital Athens, Attica, Greece

Pulmonary Dept First ICU Evangelismos Hospital Athens, Greece

View Trial Details

Completed

STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic Asthma

NCT06465485

Conditions: Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Research Site Beijing, China

Research Site Beijing, China

Research Site Beijing, China

Research Site Beijing, China

View all 74 locations

View Trial Details

Completed

Severe Asthma, MepolizumaB and Affect: SAMBA Study

NCT04680611

Conditions: Adjustment, Adjustment, Emotional, Anxiety, +27 more
Locations: Department of Respiratory Medicine, Aberdeen Royal Infirmary Aberdeen, Grampian, United Kingdom

Judit Varkonyi-Sepp Southampton, Hampshire, United Kingdom

Hull University Teaching Hospitals NHS Trust Hull, Yorkshire, United Kingdom

Pinderfields Hospital Wakefield, Yorkshire, United Kingdom

View Trial Details

Completed

A Real World Study to Capture Clinical and Patient Centered Outcomes in Adults With Severe Eosinophilic Asthma Treated With Benralizumab.

NCT05440656

Conditions: Asthma, Bronchial Diseases, Eosinophilia, +13 more
Locations: Research Site Alexandroupoli, Greece

Research Site Athens, Greece

Research Site Athens, Greece

Research Site Athens, Greece

View all 13 locations

View Trial Details

Completed

Treatment With Mepolizumab on Patients With Severe Refractory Eosinophilic Asthma

NCT05063981

Conditions: Asthma, Bronchial Diseases, Eosinophilia, +16 more
Locations: Istituti Clinici Scientifici Maugeri IRCCS Telese Terme, BN, Italy

Istituti Clinici Scientifici Maugeri IRCCS Tradate, Varese, Italy

View Trial Details

Completed

A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab

NCT04159519

Conditions: Asthma, Bronchial Diseases, Eosinophilia, +13 more
Locations: Research Site Brest, France

Research Site Dijon, France

Research Site Le Kremlin-Bicêtre, France

Research Site Lille, France

View all 23 locations

View Trial Details

Completed

Real World Evidence of Benralizumab in Eosinophilic Severe AsThma in Russia (BEST)

NCT05271526

Conditions: Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: City clinical hospital No57 Moscow, Russia

View Trial Details

Completed

Patient Reported Outcomes in Adults With Severe Eosinophilic Asthma on Benralizumab.

NCT03833141

Conditions: Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Research Site Calgary, Alberta, Canada

Research Site Calgary, Alberta, Canada

Research Site Edmonton, Alberta, Canada

Research Site Edmonton, Alberta, Canada

View all 20 locations

View Trial Details

Severe Eosinophilic Asthma

Severe Eosinophilic Asthma trial results

Related conditions